Scientific Director Oncology – ETCT Innovation

Role Summary

Scientific Director Oncology – ETCT Innovation at GSK, leading outwardly facing technology and business development initiatives to accelerate the build of a targeted biologics portfolio in Oncology. Oversees cross-functional efforts around ADC development, interfaces with internal and external partners, and advises on cutting-edge technologies and collaborations. Requires prior experience leading matrix teams in preclinical ADC development.

Responsibilities

• Guide the maturation and de-risking of novel therapeutic concepts, specifically antibody drug conjugates (ADCs), through rigorous mechanistic testing in partnership with internal and external business partners.
• Talent scout new technology investments and help build proposals for GSK‚Äôs senior leadership for investment.
• Co-lead a team which can collaborate with internal platform groups to deliver success on externally partnered programs and/or technologies.
• Identify new areas for investment at the preclinical research phase, as well as assist scientific due diligence review of in-licensing clinical opportunities with the business development organization.
• Prioritize innovation projects and allocate resources effectively to drive successful outcomes.
• Collaborate with business development teams to establish strategic partnerships and alliances with external organizations, including startups, research institutions, and pharmaceutical companies.

Qualifications

• PhD in Cancer Biology, Pharmacology, Cellular Biology, or related life science fields with 5+ years post-doctoral training.
• Experience leading cross-functional drug discovery project teams oversighting critical path chemistry and biology to develop novel therapeutic platforms for biologics targets.
• Direct experience developing ADC, and novel chemistry.
• Experience developing and implementing scientific strategies in Oncology or related disciplines with 12 to 24-month planning horizons.
• Experience in progressing ADC from concept to candidate selection and supporting critical path mechanistic biology and/or in vivo translational studies.

Skills

• Strong leadership and collaboration across matrix teams.
• Strategic thinking for preclinical investment and due diligence in oncology assets.
• Excellent communication and stakeholder management with internal and external partners.

Education

• PhD in a life sciences field as listed in Qualifications.